Evaluating Treatment Options for Opioid Use Disorder: Insights from Overdose History

By
Evan Wood
Leen Naji
August 25, 2026

Jama Network Open

Objective:

To assess the differences in treatment outcomes between methadone and buprenorphine-naloxone for individuals with opioid use disorder (OUD) who have experienced a nonfatal overdose.

Approach:

Study Overview: Kleinman et al conducted a Canadian cohort study comparing methadone and buprenorphine-naloxone initiation after overdose.
Epidemiologic Context: The study highlights the elevated risks of subsequent fatal overdose and death among individuals with a history of nonfatal overdose.

Key Findings:

Methadone initiation after overdose was associated with a survival benefit compared to buprenorphine-naloxone.
Retention rates were low for both medications, with only 25 days for methadone and 16 days for buprenorphine-naloxone.

Interpretation:

The findings indicate differences in treatment outcomes between methadone and buprenorphine-naloxone, with implications for treatment strategies.

Limitations:

Approximately 40% of eligible individuals were excluded from the study.
Potential residual confounding due to unmeasured factors such as homelessness and opioid use characteristics.

Conclusion:

The study highlights the need for improved treatment engagement and retention strategies for individuals with opioid use disorder.

Sources:

Kleinman et al Study

Evaluating Treatment Options for Opioid Use Disorder: Insights from Overdose History

Objective:

Approach:

Key Findings:

Interpretation:

Limitations:

Conclusion:

Sources:

Original Source(s)

Discerning the Forest From the Trees When Comparing Treatments for Opioid Use Disorder

Related Content

Outreach screening may uncover hearing loss

Medical Oddities: Could multilingualism keep you young?

Comparative efficacy and cognitive safety of bifrontal versus bitemporal electroconvulsive therapy in adolescents with major depressive disorder: a retrospective cohort study